IESE (España)
-
Deadly Advertising: The Tobacco Case (B)
Olale, Esther; Vaccaro, AntoninoCase BE-177-EBusiness Ethics and Corporate Social Responsibility, Corporate Governance, EconomicsThe case study analyzes the effects of the regulation of tobacco advertising on tobacco companies, the U.S. government and the final consumer from an ethical and business standpoint. The first case deals with how tobacco advertising originated and how it has evolved over the years, and the second case deals with the development of regulation to curb tobacco advertising.Starting at €5.74
-
The Clinton Economic Program
Canals, JordiCase ASE-297-EEconomicsThis case sets the ground for a discussion of the main problems of the US economy in the 1990s and the new economic plan designed by President Clinton.Starting at €8.20
-
El programa económico de Clinton
Canals, JordiCase ASE-297EconomicsEste caso prepara el terreno para una discusión de los principales problemas de la economía de Estados Unidos en los años noventa y el nuevo plan económico diseñado por el presidente Clinton.Starting at €8.20
-
La reducción de impuestos del presidente Kennedy
Canals, JordiCase ASE-208EconomicsEl caso permite discutir la efectividad de la política fiscal para estimular la actividad económica. [Es una versión abreviada y modificada del caso The Tax Cut of 1964 (ASE-24)].Starting at €8.20
-
Deadly Advertising: The Tobacco Case (A)
Olale, Esther; Vaccaro, AntoninoCase BE-176-EBusiness Ethics and Corporate Social Responsibility, Corporate Governance, EconomicsThe case study analyzes the effects of the regulation of tobacco advertising on tobacco companies, the U.S. government and the final consumer from an ethical and business standpoint. The first case deals with how tobacco advertising originated and how it has evolved over the years, and the second case deals with the development of regulation to curb tobacco advertising.Starting at €8.20
-
Glaxo: The acquisition of Wellcome
Canals, Jordi; Bardolet Urgellès, DavidCase ASE-386-EEconomicsThis case describes the changes in the world pharmaceutical industry in 1995 and presents the challenges for Glaxo (the leading European pharmaceutical firm) and the potential acquisition of Wellcome. This decision will differ from other acquisitions made by firms like Merck, oriented towards vertical integration and control over the distribution network. The main topics that the case covers are: industry analysis; value chain analysis; positioni...Starting at €8.20